Gaddafi ‘aid' adds to Sarkozy's woes

April 30, 2012

sarj_fund


Paris, April 30: The French presidential race entered the home straight on Sunday with both incumbent right-winger Nicolas Sarkozy and Socialist frontrunner Francois Hollande battling to shake off the taint of scandal.

Sarkozy accused Hollande supporters in the media of mounting a "despicable" smear against him by publishing a document purporting to show Muammar Gaddafi's former Libyan regime agreed to fund his previous presidential campaign in 2007.

Meanwhile, the Socialists were embarrassed when several senior figures in Hollande's campaign attended an ally's birthday party and found that disgraced former IMF head Dominique Strauss-Kahn had also been invited.

Both events revived interest in these long-running scandals just one week before France goes back to the polls and just days before Hollande and Sarkozy were to face off in a televised debate which could prove decisive. The latest opinion poll published by the LH2 institute for web portal Yahoo! forecast that Hollande would comfortably win the May 6 run-off by 54% of the vote to Sarkozy's 46%, a smaller gap than in LH2's last estimate. But polling has yet to take into account the effects, if any, of the latest controversies, neither of which appear fatal to either campaign, but which may reinforce the voters' disdain for the political class.

On Saturday, investigative news website Mediapart published a copy of an internal Libyan regime document recording an alleged 2006 illegal funding deal between Tripoli and Sarkozy's 2007 campaign. According to the note, which Mediapart claims to have obtained from former Libyan regime figures, Tripoli agreed to pay Sarkozy's 2007 campaign $66 million.

"It's despicable. It's a forgery . Mediapart is well used to dishonesty. It's an agency in the service of the left," Sarkozy said.

And the man to whom the memo was supposedly addressed - Bashir Saleh, Gaddafi's former chief of staff and head of Libya's 40-billion-dollar sovereign wealth fund - denied ever receiving such a communication. Meanwhile, Socialist figure Julien Dray invited Hollande's campaign director Pierre Moscovici, communications director Manuel Valls and former partner Segolene Royal to a drinks party to celebrate his birthday.

But he apparently failed to tell them he had also invited Strauss-Kahn , who is now a political pariah and under judicial investigation for his alleged ties to a prostitution network. Royal said she had left as soon as she heard Strauss-Kahn was coming, without seeing him.


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 17,2020

Beijing, Jun 17: China said Wednesday it wanted to avoid further clashes with India along their border after the first deadly confrontation between the two nuclear powers in decades.

The two countries have traded blame for Monday's high-altitude brawl that left at least 20 Indian soldiers dead, with China refusing to confirm so far whether there were any casualties on its side.

Chinese foreign ministry spokesman Zhao Lijian insisted again Wednesday that it was Indian troops who illegally crossed the border and attacked the Chinese side.

This led to "a serious physical confrontation between both sides that caused deaths and injuries", Zhao said at a regular briefing, without providing more details about the casualties.

He said China urges India to "strictly restrain frontline troops, do not illegally cross the border, do not make provocative gestures, do not take any unilateral actions that will complicate the border situation".

But he added that the two sides "will continue to resolve this issue through dialogue and negotiations".

"We of course don't wish to see more clashes," Zhao said.

Comments

Indian baba
 - 
Wednesday, 17 Jun 2020

we have 56 inch chest man as our leader...he alone will fight the war and give victory to india..jai bakth

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

Kolkata, Feb 4: A Thailand national on Tuesday gave birth during a flight from Doha to Bangkok.

The unnamed woman passenger went into labour and delivered the baby with the help of a cabin crew of Qatar airways at around 3 am.

The aircraft made the emergency landing in Kolkata and the woman was admitted to a private hospital here. Both the mother and the baby are doing fine.

"An unscheduled flight from Doha to Bangkok QR-830 landed around 03:09 am at Kolkata airport in medical priority landing. The pilot of Qatar flight had asked SOS to ATC for medical priority landing. The flight landed safely, the airport team with the doctor was attending the concerned." Kolkata Airport official said while speaking to news agency.

More details in this regard are awaited.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.